Favorites Sign in
  1. Home
  2. Companies
  3. Stock Larimar Therapeutics
Larimar Therapeutics logo

Larimar Therapeutics LRMR

$ 2.31 -16.91%
report update icon

Quarterly report 2026-Q2
added 08-04-2026

Country

 usaUSA

IPO year

 2014

Industry

 Biotechnology

Stock Exchange

 NASDAQ GLOBAL

Shares

 83.1 M

Market Cap[1]

 $ 192 M

EBITDA (LTM)

 $ -172 M

P/E (LTM)

 -2.901515

P/S (LTM)

 -

EPS (LTM)

 -1.32

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Tonix Pharmaceuticals Holding Corp. Tonix Pharmaceuticals Holding Corp.
TNXP
 		$ 4.6 -9.88 % $ 39.2 M Nasdaq Global Select Market usaUSA
NeuBase Therapeutics NeuBase Therapeutics
NBSE
 		- -1.56 % $ 12.3 M Nasdaq Global Select Market usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
 		- - $ 2.18 B Nasdaq Global Select Market,SPB usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
 		- -6.81 % $ 3.04 B Nasdaq Global Select Market,SPB usaUSA
Taysha Gene Therapies Taysha Gene Therapies
TSHA
 		$ 4.09 -6.31 % $ 1.31 B Nasdaq Global Select Market usaUSA
Scopus BioPharma Scopus BioPharma
SCPS
 		- -48.37 % $ 3.71 M Nasdaq Global Select Market usaUSA
Annovis Bio Annovis Bio
ANVS
 		$ 0.64 -46.19 % $ 13.2 M NYSE American usaUSA
scPharmaceuticals scPharmaceuticals
SCPH
 		- - $ 218 M Nasdaq Global Select Market usaUSA
Entasis Therapeutics Holdings Entasis Therapeutics Holdings
ETTX
 		- - $ 105 M Nasdaq Global Market usaUSA
Athersys Athersys
ATHX
 		- 3.77 % $ 22.4 M Nasdaq Capital Market usaUSA
Global Blood Therapeutics Global Blood Therapeutics
GBT
 		- - $ 4.62 B Nasdaq Global Select Market,SPB usaUSA
United Therapeutics Corporation United Therapeutics Corporation
UTHR
 		$ 565.49 -7.07 % $ 25.1 B Nasdaq Global Select Market,SPB usaUSA
Inozyme Pharma Inozyme Pharma
INZY
 		- - $ 207 M Nasdaq Global Select Market usaUSA
Veracyte Veracyte
VCYT
 		$ 23.51 -55.24 % $ 1.85 B Nasdaq Global Market,SPB usaUSA
Viking Therapeutics Viking Therapeutics
VKTX
 		$ 25.78 -7.83 % $ 2.9 B Nasdaq Capital Market usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
 		- -23.04 % $ 26.6 M Nasdaq Global Select Market usaUSA
Verrica Pharmaceuticals Verrica Pharmaceuticals
VRCA
 		$ 3.08 -10.85 % $ 32.8 M Nasdaq Global Market usaUSA
Viridian Therapeutics Viridian Therapeutics
VRDN
 		$ 28.53 -1.81 % $ 2.91 B Nasdaq Capital Market usaUSA
NanoString Technologies NanoString Technologies
NSTG
 		- -37.43 % $ 5.1 M Nasdaq Global Select Market usaUSA
Humanigen Humanigen
HGEN
 		- -81.12 % $ 4.28 M Nasdaq Global Select Market usaUSA
Sorrento Therapeutics Sorrento Therapeutics
SRNE
 		- -29.58 % $ 126 M Nasdaq Global Select Market usaUSA
Surface Oncology Surface Oncology
SURF
 		- - $ 59.7 M Nasdaq Global Select Market usaUSA
Immunome Immunome
IMNM
 		$ 17.86 -8.5 % $ 1.56 B Nasdaq Global Select Market usaUSA
Immuron Limited Immuron Limited
IMRN
 		$ 0.85 -0.01 % $ 196 M Nasdaq Global Select Market australiaAustralia
Sierra Oncology Sierra Oncology
SRRA
 		- -0.05 % $ 1.34 B Nasdaq Global Select Market canadaCanada
Immunic Immunic
IMUX
 		$ 7.44 -6.3 % $ 1.16 B Nasdaq Global Select Market usaUSA
Incyte Corporation Incyte Corporation
INCY
 		$ 118.15 -3.83 % $ 23.1 B Nasdaq Global Select Market,SPB usaUSA
Cocrystal Pharma Cocrystal Pharma
COCP
 		$ 1.0 -0.99 % $ 11.3 M Nasdaq Capital Market usaUSA
Atea Pharmaceuticals Atea Pharmaceuticals
AVIR
 		$ 4.2 -5.83 % $ 342 M Nasdaq Global Select Market usaUSA
Vaccinex Vaccinex
VCNX
 		- -61.37 % $ 654 K Nasdaq Global Select Market usaUSA
INmune Bio INmune Bio
INMB
 		$ 1.18 -11.14 % $ 29.2 M Nasdaq Capital Market usaUSA
Nymox Pharmaceutical Corporation Nymox Pharmaceutical Corporation
NYMX
 		- -19.68 % $ 18.4 M Nasdaq Capital Market canadaCanada
Akero Therapeutics Akero Therapeutics
AKRO
 		- - $ 3.67 B Nasdaq Global Select Market,SPB usaUSA
X4 Pharmaceuticals X4 Pharmaceuticals
XFOR
 		$ 3.06 -5.56 % $ 129 M Nasdaq Capital Market usaUSA
Xencor Xencor
XNCR
 		$ 34.0 -2.94 % $ 2.52 B Nasdaq Global Select Market,SPB usaUSA
Jounce Therapeutics Jounce Therapeutics
JNCE
 		- - $ 98.4 M Nasdaq Global Select Market usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
 		- - $ 69.7 B Nasdaq Global Select Market britainBritain
Zai Lab Limited Zai Lab Limited
ZLAB
 		$ 22.61 -0.83 % $ 24.8 B Nasdaq Global Select Market chinaChina
Zentalis Pharmaceuticals Zentalis Pharmaceuticals
ZNTL
 		$ 1.72 -2.56 % $ 124 M Nasdaq Global Market usaUSA
Corner Growth Acquisition Corp. Corner Growth Acquisition Corp.
COOL
 		- -0.89 % $ 114 M Nasdaq Global Select Market usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
 		- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
 		- -11.43 % $ 502 K NYSE American usaUSA
Ionis Pharmaceuticals Ionis Pharmaceuticals
IONS
 		$ 38.76 -3.46 % $ 6.2 B Nasdaq Global Select Market,SPB usaUSA
Akari Therapeutics, Plc Akari Therapeutics, Plc
AKTX
 		$ 7.66 -17.55 % $ 516 B Nasdaq Capital Market britainBritain
Mersana Therapeutics Mersana Therapeutics
MRSN
 		- - $ 3.56 B Nasdaq Global Select Market usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
 		- - $ 3.45 B Nasdaq Global Select Market usaUSA
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc
FRLN
 		- - $ 384 M Nasdaq Global Select Market britainBritain
Allakos Allakos
ALLK
 		- - $ 28.6 M Nasdaq Global Select Market,SPB usaUSA
Timber Pharmaceuticals Timber Pharmaceuticals
TMBR
 		- - $ 717 K NYSE American usaUSA
G1 Therapeutics G1 Therapeutics
GTHX
 		- - $ 370 M Nasdaq Global Select Market,SPB usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.